Balguid Angelique, Mol Anita, van Vlimmeren Marijke A A, Baaijens Frank P T, Bouten Carlijn V C
Eindhoven University of Technology, Department of Biomedical Engineering, Eindhoven, The Netherlands.
Circulation. 2009 Jan 20;119(2):290-7. doi: 10.1161/CIRCULATIONAHA.107.749853. Epub 2008 Dec 31.
Previous attempts in heart valve tissue engineering (TE) failed to produce autologous valve replacements with native-like mechanical behavior to allow for systemic pressure applications. Because hypoxia and insulin are known to promote protein synthesis by adaptive cellular responses, a physiologically relevant oxygen tension and insulin supplements were applied to the growing heart valve tissues to enhance their mechanical properties.
Scaffolds of rapid-degrading polyglycolic acid meshes coated with poly-4-hydroxybutyrate were seeded with human saphenous vein myofibroblasts. The tissue-engineered constructs were cultured under normal oxygen tension (normoxia) or hypoxia (7% O(2)) and incubated with or without insulin. Glycosaminoglycan production in the constructs approached that of native values under the influence of hypoxia and under the influence of insulin. Both insulin and hypoxia were associated with enhanced matrix production and improved mechanical properties; however, a synergistic effect was not observed. Although the amount of collagen and cross-links in the engineered tissues was still lower than that in native adult human aortic valves, constructs cultured under hypoxic conditions reached native human aortic valve levels of tissue strength and stiffness after 4 weeks of culturing.
These results indicate that oxygen tension may be a key parameter for the achievement of sufficient tissue quality and mechanical integrity in tissue-engineered heart valves. Engineered tissues of such strength, based on rapid-degrading polymers, have not been achieved to date. These findings bring the potential use of tissue-engineered heart valves for systemic applications a step closer and represent an important improvement in heart valve tissue engineering.
以往心脏瓣膜组织工程(TE)的尝试未能制造出具有类似天然机械性能的自体瓣膜置换物,以适应体循环压力。由于已知缺氧和胰岛素可通过适应性细胞反应促进蛋白质合成,因此将生理相关的氧张力和胰岛素补充剂应用于生长中的心脏瓣膜组织,以增强其机械性能。
将涂有聚-4-羟基丁酸酯的快速降解聚乙醇酸网支架接种人隐静脉肌成纤维细胞。将组织工程构建体在正常氧张力(常氧)或缺氧(7% O₂)条件下培养,并在有或无胰岛素的情况下孵育。在缺氧和胰岛素的影响下,构建体中糖胺聚糖的产生接近天然值。胰岛素和缺氧均与基质产生增加和机械性能改善有关;然而,未观察到协同效应。尽管工程组织中的胶原蛋白和交联量仍低于天然成人主动脉瓣,但在缺氧条件下培养4周后,构建体的组织强度和刚度达到了天然人类主动脉瓣水平。
这些结果表明,氧张力可能是在组织工程心脏瓣膜中实现足够组织质量和机械完整性的关键参数。基于快速降解聚合物的具有这种强度的工程组织迄今尚未实现。这些发现使组织工程心脏瓣膜在体循环应用中的潜在用途更近了一步,代表了心脏瓣膜组织工程的一项重要进展。